These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34981706)

  • 1. Complete Recovery After Immunosuppressive Treatment Change in a Patient With Posttransplant Lymphoproliferative Disorder.
    Arı D; Turan D; Gökcan H; Özdemir M; Akdoğan Kayhan M
    Exp Clin Transplant; 2023 Jan; 21(1):76-79. PubMed ID: 34981706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttransplant Lymphoproliferative Disorders Presenting as an External Nasal Deformity: A Case Report.
    Yuan J; Yan Z; Liu J; Wang N
    Ear Nose Throat J; 2021 Sep; 100(5_suppl):614S-617S. PubMed ID: 31910671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent Intestinal Perforation After Cessation of Immunosuppression in Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipient.
    Valamparampil JJ; Palaniappan K; Vij M; Shanmugam N; Ramachandran P; Ramachandran B; Rela M
    J Gastrointest Cancer; 2021 Sep; 52(3):1165-1168. PubMed ID: 33751328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictable and Unusual Adverse Effects of Immunosuppression in Pediatric Liver Transplant Patients.
    Öztürk H; Ekşi Bozbulut N; Sarı S; Eğritaş Gürkan Ö; Sözen H; Sapmaz A; Dalgıç A; Dalgıç B
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):230-233. PubMed ID: 30777562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow involvement by lymphoproliferative disorders after solid-organ transplant.
    Akar Özkan E; Özdemir BH; Yılmaz Akçay E; Terzi A; Karakuş S; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():183-7. PubMed ID: 25894151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
    Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttransplant lymphoproliferative disorder after liver and kidney transplant.
    Akar Özkan E; Özdemir BH; Deniz EE; Tunca MZ; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():142-8. PubMed ID: 24635813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumor as an unusual presentation of posttransplant lymphoproliferative disorder.
    Azarpira N; Torabineghad S; Rakei M
    Exp Clin Transplant; 2009 Mar; 7(1):58-61. PubMed ID: 19364315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete response to post-transplant lymphoproliferative disorder by surgical resection and rituximab after living-donor liver re-transplantation for recurrent primary sclerosing cholangitis.
    Haruki K; Shiba H; Shimada J; Okui N; Iida T; Yanaga K
    Clin J Gastroenterol; 2017 Feb; 10(1):47-51. PubMed ID: 27796825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation.
    Koffman BH; Kennedy AS; Heyman M; Colonna J; Howell C
    Int J Cancer; 2000 Apr; 90(2):104-9. PubMed ID: 10814960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous Manifestations of Posttransplant Lymphoma in Renal Transplant Recipients: A Case Series.
    Patil R; Prashar R; Patel A
    Transplant Proc; 2021 Jun; 53(5):1519-1527. PubMed ID: 34134932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational management of posttransplant lymphoproliferative disorder in pediatric recipients.
    Praghakaran K; Wise B; Chen A; Schwarz K; Colombani P
    J Pediatr Surg; 1999 Jan; 34(1):112-5; discussion 115-6. PubMed ID: 10022154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early signs and risk factors for the increased incidence of Epstein-Barr virus-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus.
    Sokal EM; Antunes H; Beguin C; Bodeus M; Wallemacq P; de Ville de Goyet J; Reding R; Janssen M; Buts JP; Otte JB
    Transplantation; 1997 Nov; 64(10):1438-42. PubMed ID: 9392308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
    Arita H; Izumoto S; Kinoshita M; Okita Y; Hashimoto N; Fujita T; Ichimaru N; Takahara S; Yoshimine T
    Neurol Med Chir (Tokyo); 2010; 50(12):1079-83. PubMed ID: 21206182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
    Akar Özkan E; Özdemir BH; Akdur A; Deniz EE; Haberal M
    Exp Clin Transplant; 2014 Mar; 12 Suppl 1():136-8. PubMed ID: 24635811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-of-Treatment Positron Emission Tomography After Uniform First-Line Therapy of B-Cell Posttransplant Lymphoproliferative Disorder Identifies Patients at Low Risk of Relapse in the Prospective German PTLD Registry.
    Zimmermann H; Denecke T; Dreyling MH; Franzius C; Reinke P; Subklewe M; Amthauer H; Kneba M; Riess H; Trappe RU
    Transplantation; 2018 May; 102(5):868-875. PubMed ID: 29189632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
    Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report: hepatic posttransplant lymphoproliferative disorder in a non-liver transplant patient.
    Koyun M; Hazar V; Akkaya B; Comak E; Gökçeoğlu AU; Doğan CS; Çubuk SM; Akman S
    Transplant Proc; 2011 Jun; 43(5):2102-6. PubMed ID: 21693336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Small Intestine Posttransplant Lymphoproliferative Disorder in a Kidney Transplant Recipient: A Case Report.
    Radunovic D; Dapcevic M; Prelevic V; Tomovic F; Ratkovic M; Basic-Jukic N
    Exp Clin Transplant; 2021 Jan; 19(1):77-79. PubMed ID: 33441059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy.
    Cacciarelli TV; Green M; Jaffe R; Mazariegos GV; Jain A; Fung JJ; Reyes J
    Transplantation; 1998 Oct; 66(8):1047-52. PubMed ID: 9808490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.